CytoSorbents Achieves Record Total Revenue and CytoSorb Sales in the Second Quarter 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
CytoSorbents (CTSO) PT Raised to $18 at Maxim Group
August 3, 2018 7:36 AM EDTMaxim Group raised its price target on CytoSorbents (NASDAQ: CTSO) to $18.00 (from $13.00) while maintaining a Buy rating.
Analsyt Jason McCarthy commented:
Cytosorbents reported another quarter of growth with Cytosorb revenues of $5.24M, up sequentially from $4.4Mthe 24th consecutive quarter of y/y... MoreCytoSorbents (CTSO) PT Raised to $15 at Cowen
August 3, 2018 6:42 AM EDTCowen raised its price target on CytoSorbents (NASDAQ: CTSO) to $15.00 (from $13.00) while maintaining an Outperform rating.
Analyst Josuah Jennings commented, "CTSO again delivered impressive quarterly revenue growth, with product sales of $5.2M, up 72% from last year. Lead product CytoSorb has numerous tailwinds in 2018, including (1) favorable German... More
Cytosorbents (CTSO) Misses Q2 EPS by 7c
August 2, 2018 4:51 PM EDTCytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.19), $0.07 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $5.07 million.
Ended Q2 2018 with $25.3 million in cash and cash equivalents.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
... More